Dg. Contopoulosioannidis et Jpa. Ioannidis, MATERNAL CELL-FREE VIREMIA IN THE NATURAL-HISTORY OF PERINATAL HIV-1 TRANSMISSION - A METAANALYSIS, Journal of acquired immune deficiency syndromes and human retrovirology, 18(2), 1998, pp. 126-135
We performed a meta-analysis of the predictive value of maternal cell-
free viral load in vertical HIV-1 transmission, including 9 cohorts wi
th 1115 mother-infant pairs (696 untreated and 419 treated women). The
pooled rate of transmission in untreated women was 21.3% (95% confide
nce interval [CI], 18.3%-24.5%). The rates of transmission for untreat
ed women in the <1000 copies/ml, 1000 to 9999 copies/ml, and greater t
han or equal to 10,000 copies/ml categories were 5% (95% CI, 2%-11%),
15% (95% CI, 11%-20%) and 37% (95% CI, 29%-46% by random effects), res
pectively. The area under the receiver operating characteristic (ROC)
curve in individual studies ranged from 0.67 to 1.00. The predictive p
erformance of RNA differed between cohorts in which different percenta
ges of transmitters had RNA values >10,000 copies/ml. When 95% of tran
smitters have RNA values >1000 copies/ml, 77% of nontransmitters would
also have values above this cutoff Transmission rates for treated wom
en in the 1000 to 9999 copies/ml category (7%; 95% CI, 4%-11%,) and gr
eater than or equal to 10,000 copies/ml category (18%; 95% CI, 12%-27%
) were probably lower than those for untreated women, whereas the tran
smission rate for treated women with <1000 copies/ml was 5% (95% CI, 2
%-11%). Thus, the risk gradient between RNA categories seems attenuate
d in treated women. Several aspects of the design, analysis, and repor
ting of research in this area may be improved in the future with atten
tion to selection and observer biases, multivariate adjustment, and te
chnical consistency. Maternal HIV-1 RNA is a modest predictor of trans
mission for individual mothers, but a strong predictor of the average
risk in groups of untreated mothers. Its discriminatory power is bette
r in untreated than in treated populations and is better in cohorts wi
th a high prevalence of elevated viral load values than in cohorts wit
h generally low levels of viremia.